Skip to main content
logo
Raphael Pharmaceutical Inc. (RAPH)
OTCMKTS · Delayed Price · Currency is USD
1.400
0.00 (0.00%)
At close: Jul 28, 2026

Raphael Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2827519--
Market Cap Growth
91.90%465.09%-73.72%---
Enterprise Value
2828518--
Last Close Price
1.401.400.261.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
-17.00-19.17-6.55172.92--
P/TBV Ratio
---172.92--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.02-0.02-0.05---
Net Debt / Equity Ratio
-0.020.01-0.03-2.15-2.72-1.19
Net Debt / FCF Ratio
-0.800.05-0.040.190.380.11
Quick Ratio
0.000.030.031.801.440.83
Current Ratio
0.000.030.031.801.461.44
Return on Equity (ROE)
----1261.97%-2870.09%-3821.18%
Return on Assets (ROA)
-1358.07%-1945.31%-709.12%-291.08%-549.17%-273.32%
Return on Capital Employed (ROCE)
62.80%86.90%203.40%-1244.90%-3129.20%-1272.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.82%-4.66%-31.24%-7.26%--
FCF Yield
-0.16%-0.76%-10.94%-6.50%--
Buyback Yield / Dilution
-4.03%-4.70%-11.71%-16.56%-28.37%-18.10%